By 2030, the Off-the-Shelf Second-Hand Furniture Industry is Expected to Witness a Revenue Surge, Projected at USD 58.58 Billion with a Notable CAGR of 7.80%, States Straits Research
January 18, 2024 09:20 ET
|
Straits Research
New York, United States, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Due to people fleeing to different cities because of the coronavirus lockdowns, unemployed millennials returning to live with their...
Tessa Therapeutics’ ‘Off-the-Shelf’ CAR-T Therapy Shows Promising Results in Early-Stage Study of Hodgkin Lymphoma
June 15, 2023 21:19 ET
|
Tessa Therapeutics Ltd
78% Overall Response Rate (14/18 patients), including seven patients exhibiting a complete response to TT11X allogeneic CAR-T therapySafety data encouraging with no graft-versus-host-disease and no...
Edmund Optics® Receives the 2022 Silver Innovators Award by Vision Systems Design for Developing New, Off-the-Shelf Athermal Imaging Lenses
June 07, 2022 09:00 ET
|
Edmund Optics
BARRINGTON, N.J., June 07, 2022 (GLOBE NEWSWIRE) -- Edmund Optics®, a leading global manufacturer and supplier of optical components, is the 2022 recipient of the Silver-Level Innovators Award by...
Tessa Therapeutics Showcases Positive Clinical Data from Phase 1 Study of “Off the Shelf” CD30 Cell Therapy at 2021 Annual Meeting of American Society of Hematology (ASH)
December 11, 2021 18:00 ET
|
Tessa Therapeutics Ltd
Oral poster presentation highlights data from dose-escalation trial of allogeneic CD30.CAR EBVST cell therapy (TT11X) in patients with relapsed or refractory CD30-positive lymphomas Results...
New Integrated Tank Mount Series with Off-the-Shelf Availability for Process Weighing Applications
September 01, 2020 08:00 ET
|
Vishay Precision Group
MALVERN, Pa., Sept. 01, 2020 (GLOBE NEWSWIRE) -- BLH Nobel, a brand of Vishay Precision Group, Inc. (NYSE: VPG), today introduced its Tank Mount Series of weighing equipment for process weighing...
Adaptimmune to Present Data Demonstrating that its Off-the-shelf Process Produces T-cells from Stem Cells that Respond to Cancer Targets with a SPEAR TCR at ASGCT Meeting
May 02, 2019 07:00 ET
|
Adaptimmune Therapeutics plc
- Data show strong progress with off-the-shelf program demonstrating T-cell differentiation from stem cells (hiPSC) in a serum-free process without the addition of mouse stromal cells - - Lentiviral...